Format

Send to

Choose Destination
Leukemia. 2014 Feb;28(2):248-57. doi: 10.1038/leu.2013.192. Epub 2013 Jun 25.

STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.

Author information

1
Department of Medicine, University of Pittsburgh and the University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
2
Department of Microbiology and Immunology, School of Medicine, East Carolina University, Greenville, NC, USA.
3
Department of Pharmacology and Chemical Biology, University of Pittsburgh and the University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.

Abstract

Signal transducer and activator of transcription (STAT) proteins comprise a family of transcription factors that are activated by cytokines, hormones and growth factors. The activation of STAT proteins plays a key role in the production of mature hematopoietic cells via effects on cellular proliferation, survival and lineage-specific differentiation. Emerging evidence also demonstrates frequent, constitutive activation of STATs in primary leukemia specimens. Moreover, roles for STATs in promoting leukemia development have been delineated in numerous preclinical studies. This review summarizes our current understanding of STAT protein involvement in normal hematopoiesis and leukemogenesis, as well as recent advances in the development and testing of novel STAT inhibitors.

PMID:
23797472
DOI:
10.1038/leu.2013.192
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center